You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
ENCAPSULATED TRANSFECTED CELLS AS A THERAPY FOR MS
SBC: Cytotherapeutics, Inc. Topic: N/AN/A
STTR Phase I 1998 Department of Health and Human Services -
Improved Capacitor Using Amorphous RuO2
SBC: EVANS CAPACITOR COMPANY Topic: N/AAmorphous hydrous ruthenium oxide(Ru02.xH20A) has a specific capacitance at least two times larger than any other known capacitor materials. An object of this proposal is to demostrate the feasibility of producing shock-hardened RuO2. H2O based electrochemical capacitors suitable for use in power sources for advanced weapon system applications. A 25 V, 150 mF shock-hardened electrochemical capa ...
STTR Phase I 1998 Department of DefenseAir Force -
PHOTOFENTON REAGENTS AS PDT SENSITIZERS
SBC: LAMBDA PHARMACEUTICALS Topic: N/AN/A
STTR Phase I 1998 Department of Health and Human Services -
Nonintrusive Diagnostics for Off-Body Measurements in Flight Experiments
SBC: INNOVATIVE TECH APPLICATIONS LLC Topic: AF10BT07ABSTRACT: Flight tests of hypersonic maneuvering vehicles are a challenging but necessary endeavor. While ground tests and numerical simulations can provide important guidance regarding vehicle performance, they are both limited in their reach. Likewise surface-based measurements during flight tests provide valuable information, but do not provide sufficient insight into the complex flowfield t ...
STTR Phase I 2011 Department of DefenseAir Force -
Tiptuximab Immunotherapeutic for Cancer
SBC: Medical Guidance Systems LLC Topic: NCI? DESCRIPTION (provided by applicant): Poor prognosis cancers such as lung cancer, glioblastoma, pancreatic cancer and others have 3 year survival rates that range from 1%-15%. Recent advancements in the development of therapeutic antibodies haveshown promise in other cancers such as breast, head and neck, and colon cancer. The limitations in antibody development are the paucity of cancer ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Galectin 1: A novel small protein therapy for Duchenne muscular dystrophy
SBC: STRYKAGEN CORPORATION Topic: NIAMSDESCRIPTION provided by applicant Duchenne Muscular Dystrophy DMD is a fatal muscle disease affecting in every male births DMD results from mutations in the gene encoding the dystrophin a kDa scaffolding protein responsible for providing a mechanical link between the muscle fiber actin cytoskeleton and a transmembrane protein complex called the dystrophin associated glycoprotein ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Identification of Borrelia burgdorferi diagnostic biomarkers in humans and nonhum
SBC: DXDISCOVERY INC Topic: NIAIDDESCRIPTION provided by applicant The number of Lyme disease cases in the US has been recently estimated by the CDC at cases year This is major public health concern Currently available diagnostics rely on detection of the antibody response serology to Borrelia burgdorferi the causative agent of Lyme disease However serological tests are not accurate during the early stages of Ly ...
STTR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health -
Prediction and Measurement of the Carbon Build-Up in Film-Cooled Rocket Engines
SBC: SIERRA ENGINEERING, INC. Topic: AF15AT21ABSTRACT: Sierra Engineering Inc. (Sierra) believes that existing chemical kinetic models can be efficiently incorporated into commercial CFD codes to predict the mixing, pyrolysis, soot formation and carbon deposition within film cooled rocket engines. During this Phase I STTR effort we will demonstrate that this analysis capability is practical and that we can generate appropriate model validati ...
STTR Phase I 2015 Department of DefenseAir Force -
New Assays for Expression Profiling of MicroRNAs
SBC: Nawgen, LLC Topic: 172DESCRIPTION provided by applicant MicroRNAs miRNAs are involved in many diverse biological processes and a single miRNA can modulate the expression of hundreds of gene targets Changes in miRNA expression could have profound biological impacts leading to a variety of human diseases To date most miRNA expression profiling studies have relied on microarrays or high throughput RNA sequencing ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health -
Rational design of small interfering RNA for genome-wide target knockdown
SBC: Nawgen, LLC Topic: 172DESCRIPTION provided by applicant RNA interference RNAi is a small RNA guided gene silencing process within living cells The RNAi technique is widely used in both biological research and clinical applications because it has the ability to knockdown essentially any gene of interest However one major unresolved issue in RNAi studies is non specific gene silencing It is well known that in ...
STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health